HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thierry Guillaume Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

1/2024Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
1/2024Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.
2/2023[Cardiac complications following allogeneic hematopoietic stem cell transplantation: Recommendations of the SFGM-TC].
1/2023Post-transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced-intensity conditioning allotransplant.
10/2021Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis.
4/2021Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
1/2020Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution.
1/2020Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograft.
1/2019Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide.
2/2018Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thierry Guillaume Research Topics

Disease

16Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 09/2005
16Neoplasms (Cancer)
01/2024 - 09/2002
15Graft vs Host Disease (Graft-Versus-Host Disease)
01/2024 - 01/2010
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2021 - 09/2014
6Hematologic Neoplasms (Hematological Malignancy)
10/2021 - 12/2009
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 12/2013
5Multiple Myeloma
01/2021 - 06/2012
4Leukemia
11/2023 - 04/2015
3Bronchiolitis Obliterans Syndrome
10/2021 - 01/2017
3Disease Progression
06/2019 - 07/2011
3Hematologic Diseases (Blood Diseases)
01/2019 - 02/2005
3Breast Neoplasms (Breast Cancer)
03/2012 - 09/2002
2Infections
01/2023 - 10/2018
2Lymphopenia (Lymphocytopenia)
08/2021 - 01/2020
2Hodgkin Disease (Hodgkin's Disease)
01/2019 - 01/2018
2Invasive Fungal Infections
01/2018 - 04/2015
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2012 - 07/2011
1Inborn Genetic Diseases (Disease, Hereditary)
04/2024
1Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
04/2024
1Myeloid Leukemia (Leukemia, Myelocytic)
11/2023
1Hemorrhagic Cystitis
02/2023
1Cystitis
02/2023
1COVID-19
12/2022
1Aplastic Anemia (Anemia, Hypoplastic)
11/2022
1Severe Acute Respiratory Syndrome
05/2022
1Macrophage Activation Syndrome
01/2022
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2022
1Cadaver (Cadavers)
10/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Renal Insufficiency (Renal Failure)
01/2020
1Lymphoma (Lymphomas)
01/2019
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019
1Pathologic Complete Response
11/2018
1Fatigue
01/2018
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2018
1Primary Myelofibrosis (Myelosclerosis)
07/2017
1Virus Diseases (Viral Diseases)
01/2017
1Juvenile Myelomonocytic Leukemia
12/2016
1Acute Promyelocytic Leukemia
10/2016
1Myeloproliferative Disorders (Myeloproliferative Disorder)
04/2015
1Prolymphocytic Leukemia
03/2015

Drug/Important Bio-Agent (IBA)

9Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2024 - 02/2018
7Clofarabine (Clolar)FDA Link
08/2020 - 11/2016
5Busulfan (Busulfex)FDA Link
01/2020 - 11/2011
4AntibodiesIBA
05/2022 - 09/2002
4Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2020 - 11/2011
3Azacitidine (5 Azacytidine)FDA Link
10/2021 - 11/2019
3Cytarabine (Cytosar-U)FDA LinkGeneric
08/2020 - 11/2008
3epratuzumabIBA
01/2017 - 12/2013
3fludarabineIBA
11/2016 - 11/2011
3Gemtuzumab (Mylotarg)FDA Link
01/2016 - 09/2005
2VaccinesIBA
05/2022 - 10/2021
2Proteasome InhibitorsIBA
06/2019 - 06/2019
2Dexamethasone (Maxidex)FDA LinkGeneric
06/2019 - 04/2015
2Monoclonal AntibodiesIBA
06/2019 - 01/2019
2flt3 ligand protein (flt3 ligand)IBA
01/2019 - 01/2019
2Mitoxantrone (Novantrone)FDA LinkGeneric
11/2008 - 09/2005
2Immunoglobulin Fab FragmentsIBA
07/2004 - 09/2002
2AntigensIBA
07/2004 - 09/2002
2Proteins (Proteins, Gene)FDA Link
07/2004 - 09/2002
1Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
04/2024
1Zoledronic Acid (Zometa)FDA Link
01/2024
1Interleukin-2 (IL2)IBA
01/2024
1Messenger RNA (mRNA)IBA
12/2022
1mRNA VaccinesIBA
11/2022
1tisagenlecleucelIBA
01/2022
1etoposide phosphate (Etopophos)FDA Link
01/2022
1Ferritins (Ferritin)IBA
10/2021
1CytokinesIBA
01/2021
1eltrombopagFDA Link
01/2021
1Immunotoxins (Immunotoxin)IBA
07/2020
1purineIBA
01/2020
1pomalidomideIBA
06/2019
1daratumumabIBA
06/2019
1Lenalidomide (CC 5013)FDA Link
06/2019
1Fluorine-18IBA
01/2019
1N 30IBA
02/2018
1posaconazoleFDA Link
01/2018
1TabletsIBA
01/2018
1Rituximab (Mabthera)FDA Link
01/2018
1Bortezomib (Velcade)FDA Link
12/2017
1Janus Kinase InhibitorsIBA
07/2017
1Dihydrotachysterol (AT 10)IBA
01/2017
1Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2016
1Arsenic Trioxide (Trisenox)FDA Link
10/2016
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2016
1Fluconazole (Zonal)FDA LinkGeneric
04/2015
1Vincristine (Oncovin)FDA LinkGeneric
04/2015

Therapy/Procedure

20Hematopoietic Stem Cell Transplantation
04/2024 - 03/2015
17Stem Cell Transplantation
04/2024 - 01/2010
13Therapeutics
03/2023 - 11/2008
12Transplantation
01/2024 - 12/2009
5Drug Therapy (Chemotherapy)
08/2021 - 09/2005
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2023 - 12/2016
4Cell Transplantation
02/2023 - 02/2015
4Homologous Transplantation
10/2021 - 04/2015
2Radioimmunotherapy
12/2013 - 06/2012
1Salvage Therapy
10/2018
1Induction Chemotherapy
01/2018
1Cell- and Tissue-Based Therapy (Cell Therapy)
12/2016